HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GD3-lactone-KLH

structure in first source

Also Known As:

GD3-L-KLH

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycolipids: 2799
    - Glycosphingolipids: 1659
      - Acidic Glycosphingolipids: 20
        Gangliosides: 3319
        GD3-lactone-KLH: 2
Lipids: 114793
- Glycolipids: 2799
  - Glycosphingolipids: 1659
    - Acidic Glycosphingolipids: 20
      - Gangliosides: 3319
        GD3-lactone-KLH: 2
- Membrane Lipids: 1591
  - Sphingolipids: 3208
    - Glycosphingolipids: 1659
      - Acidic Glycosphingolipids: 20
        Gangliosides: 3319
        GD3-lactone-KLH: 2

Experts

1.	Chapman, Paul B: 1 article (07/2004)
2.	Hwu, Wen-Jen: 1 article (07/2004)
3.	Johnson, Diantha: 1 article (07/2004)
4.	Livingston, Philip O: 1 article (07/2004)
5.	Lu, Sharon: 1 article (07/2004)
6.	Ragupathi, Govind: 1 article (07/2004)
7.	Williams, Linda: 1 article (07/2004)
8.	Wu, Dianna: 1 article (07/2004)
9.	Adluri, S: 1 article (03/2000)
10.	Howard, L: 1 article (03/2000)

Related Diseases

1.

Melanoma (Melanoma, Malignant)

07/15/2004 - "Twenty-four melanoma patients were randomized to be immunized with either BEC2 followed by GD3-L-KLH or in the opposite order. "
03/01/2000 - "In our continuing efforts to induce antibody against GD3, we have immunized groups of 6 melanoma patients with GD3-KLH or GD3-L-KLH conjugates containing 30 microg of ganglioside plus 100 microg of QS-21 at 0, 1, 2, 3, 7 and 19 weeks. "
03/01/2000 - "Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21."

Related Drugs and Biologics

1.	Gangliosides
2.	Antibodies
3.	Immunologic Adjuvants (Immunologic Adjuvant)
4.	saponin QA-21V1 (QS21)
5.	GD3 ganglioside (GD(3))